Feedback Last updated on Jan 20, 2024 Photo by Tapish / Unsplash Previous Publications Update # 44 Next NRG-GY012: Olaparib, Cediranib, and Olaparib+Cediranib vs. Cediranib in Recurrent Endometrial Cancer
